Revenue | ₹13,571.71Cr |
Net Profits | ₹2,149.88Cr |
Net Profit Margins | 15.84% |
Sun Pharmaceutical Industries Ltd’s revenue jumped 7.81% since last year same period to ₹13,571.71Cr in the Q4 2024-2025. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated -4.03% fall in its revenue since last 3-months.
Sun Pharmaceutical Industries Ltd’s net profit fell -19.01% since last year same period to ₹2,149.88Cr in the Q4 2024-2025. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated -25.95% fall in its net profits since last 3-months.
Sun Pharmaceutical Industries Ltd’s net profit margin fell -24.88% since last year same period to 15.84% in the Q4 2024-2025. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated -22.85% fall in its net profit margins since last 3-months.
The revenue for Sun Pharmaceutical Industries Ltd in the Q4 results 2024 was ₹13,571.71Cr.
The net profit for Sun Pharmaceutical Industries Ltd in the Q4 results 2024 was ₹2,149.88Cr.
The net profit margin for Sun Pharmaceutical Industries Ltd in the Q4 results 2024 was 15.84%.
The revenue for Sun Pharmaceutical Industries Ltd in the Q4 results 2023 was ₹12,588.84Cr.
The net profit for Sun Pharmaceutical Industries Ltd in the Q4 results 2023 was ₹2,654.58Cr.
The net profit margin for Sun Pharmaceutical Industries Ltd in the Q4 results 2023 was 21.09%.